Zosano Pharma Raises $45M
Fremont-based Zosano Pharma said Thursday that it has raised $45M, in the second close of a $90M initial venture capital round. The firm, which is developing drug delivery products, said that New Enterprise Associates (NEA), Nomura Phase4 Ventures, HBM BioVentures and ProQuest Investments invested in the second close. Zosano is developing a patch for treating osteoporosis, and is in Phase 2 development. Zosano was formerly known as Macroflux.
posted on Friday, November 16, 2007 (Link to more information)
Related companies:
Zosano Pharma FKA Macroflux
Related stories:
> Zosano Pharma Expected To IPO Next Week
> Zosano Pharma Raises $30M
> Antiva Biosciences Raises $22M
> Circle Pharma Ups Funding To $6.5M
> ROXRO PHARMA Gets $42.7M
silicontap.com Home